Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02562469 · ClinicalTrials.gov registry record · NA

ACTIVATE: A Computerized Training Program for Children With ADHD

A NA study of ADHD, sponsored by New York University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT02562469 is a NA study of ADHD that has completed, run by New York University. The registered enrollment target is 20 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02562469, a NA study of ADHD, has completed, sponsored by New York University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

A preliminary clinical trial of ACTIVATE will be conducted in a sample of children with ADHD. ACTIVATE is a computerized neurocognitive training program (ACTIVATE; see: www.c8sciences.com) that simultaneously targets eight core neurocognitive factors (i.e., sustained attention, working memory (WM), response inhibition, speed of information processing, cognitive flexibility and control, multiple simultaneous attention, category formation, and pattern recognition and inductive thinking).

Conditions Studied

Interventions

  • OTHER ACTIVATE

Study Locations (1)

New York

  • New York University - New York

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2015-09
Est. Completion 2017-08
Phase NA

Sponsor

New York University

83 total trials

What the Registry Record Tells You About NCT02562469

The ClinicalTrials.gov registry entry for NCT02562469 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (89% lower). The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which ACTIVATE is the first listed.

NCT02562469 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02562469 about?

NCT02562469 is a clinical study titled "ACTIVATE: A Computerized Training Program for Children With ADHD". A preliminary clinical trial of ACTIVATE will be conducted in a sample of children with ADHD. ACTIVATE is a computerized neurocognitive training program (ACTIVATE; see: www.c8sciences.com) that simultaneously targets eight core neurocognitive factors (i.e., sustained attention, working memory (WM), ...

What is the current status of trial NCT02562469?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-09. Estimated completion is 2017-08.

What conditions does trial NCT02562469 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT02562469?

The interventions under investigation include: ACTIVATE (OTHER).

Who is sponsoring clinical trial NCT02562469?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02562469 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.